Molecular Docking studies of FKBP12-mTOR inhibitors using binding predictions

Mammalian target of rapamycin (mTOR) is a key regulator of cell growth, proliferation and angiogenesis. mTOR signaling is frequently hyper activated in a broad spectrum of human cancers thereby making it a potential drug target. The current drugs available have been successful in inhibiting the mTOR...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasr, Arash Boroumand, Ponnala, Deepika, Sagurthi, Someshwar Rao, Kattamuri, Ramesh Kumar, Marri, Vijaya Kumar, Gudala, Suresh, Lakkaraju, Chandana, Bandaru, Srinivas, Nayarisseri, Anuraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2015
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512006/
https://www.ncbi.nlm.nih.gov/pubmed/26229292
http://dx.doi.org/10.6026/97320630011307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512006/
https://www.ncbi.nlm.nih.gov/pubmed/26229292
http://dx.doi.org/10.6026/97320630011307

Ejemplares similares